Young James Emmett
CIK 0002050748
Chief Financial Officer
Filings
4
Latest May 21, 2025
Issuers covered
1
Showing
4 of 4
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +2.6% | +2.6% | +4.7% | +0.6% |
| 90 days | 2 | 50% | +2.2% | +2.2% | +7.9% | -3.6% |
| 180 days | 2 | 0% | -17.7% | -17.7% | -14.2% | -21.2% |
| 365 days | 2 | 0% | -6.9% | -6.9% | -1.5% | -12.2% |
Issuers
Companies where Young James Emmett has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TLSI | Trisalus Life Sciences, Inc. | 4 | May 21, 2025 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|